Vault-13

FRAZIER MANAGEMENT LLC

SEATTLE, WA · CIK 1032165 · 13F filing filed 2021-05-12

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

As an employer

US visa salary filings

Job titleFilingsMedianRange
Associate, Investment AnalystSeattle, WA 1 $125,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Frazier Management LLC.

$1.2bn reported value -4.0% vs Q4 2020
35positions
77.8%in top 10
4 new 7 added 2 reduced 4 sold out vs Q4 2020

Holdings, Q1 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 10,542,790 $305.0m24.46% 24.46% UnchangedShares held: Q2 2020 10.5m, Q3 2020 10.5m, Q4 2020 10.5m, Q1 2021 10.5m
2 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 5,827,415 $218.9m17.56% 17.56% UnchangedShares held: Q2 2020 5.8m, Q3 2020 5.8m, Q4 2020 5.8m, Q1 2021 5.8m
3 PASSAGE BIO INC COM COM 5,009,219 $87.6m7.02% 7.02% UnchangedShares held: Q2 2020 5.0m, Q3 2020 5.0m, Q4 2020 5.0m, Q1 2021 5.0m
4 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 3,566,912 $70.7m5.67% 5.67% UnchangedShares held: Q2 2020 3.6m, Q3 2020 3.6m, Q4 2020 3.6m, Q1 2021 3.6m
5 KRYSTAL BIOTECH INC COM KRYS KRYS 895,000 $69.0m5.53% 5.53% UnchangedShares held: Q2 2020 895.0k, Q3 2020 895.0k, Q4 2020 895.0k, Q1 2021 895.0k
6 TARSUS PHARMACEUTICALS INC COM TARS TARS 1,917,157 $61.8m4.96% 4.96% UnchangedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 1.9m, Q1 2021 1.9m
7 VAXCYTE INC COM PCVX PCVX 2,309,554 $45.6m3.66% 3.66% UnchangedShares held: Q2 2020 2.3m, Q3 2020 2.3m, Q4 2020 2.3m, Q1 2021 2.3m
8 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 1,312,999 $41.6m3.33% 3.33% UnchangedShares held: Q2 2020 1.3m, Q3 2020 1.3m, Q4 2020 1.3m, Q1 2021 1.3m
9 TRANSLATE BIO INC COM COM 2,182,789 $36.0m2.89% 2.89% UnchangedShares held: Q2 2020 2.2m, Q3 2020 2.2m, Q4 2020 2.2m, Q1 2021 2.2m
10 TRILLIUM THERAPEUTICS INC COM NEW TR TR 3,123,107 $33.4m2.68% 2.68% AddedShares held: Q2 2020 2.8m, Q3 2020 2.8m, Q4 2020 3.1m, Q1 2021 3.1m +70.0k +70,000 2.3%
11 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 1,435,045 $32.1m2.57% 2.57% AddedShares held: Q2 2020 1.3m, Q3 2020 1.3m, Q4 2020 1.4m, Q1 2021 1.4m +30.0k +30,000 2.1%
12 ALPINE IMMUNE SCIENCES INC COM NVLS NVLS 2,571,450 $27.3m2.19% 2.19% UnchangedShares held: Q2 2020 2.6m, Q3 2020 2.6m, Q4 2020 2.6m, Q1 2021 2.6m
13 SUTRO BIOPHARMA INC COM COM 1,001,421 $22.8m1.83% 1.83% UnchangedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 1.0m, Q1 2021 1.0m
14 ANAPTYSBIO INC COM ANAB ANAB 899,700 $19.4m1.56% 1.56% UnchangedShares held: Q2 2020 2.3m, Q3 2020 2.3m, Q4 2020 899.7k, Q1 2021 899.7k
15 ACLARIS THERAPEUTICS INC COM ACRS ACRS 696,000 $17.5m1.41% 1.41% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 696.0k
16 MOLECULAR TEMPLATES INC COM COM 1,374,047 $17.3m1.39% 1.39% AddedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 841.9k, Q1 2021 1.4m +532.1k +532,139 63.2%
17 IVERIC BIO INC COM OPHT OPHT 2,544,500 $15.7m1.26% 1.26% AddedShares held: Q2 2020 2.4m, Q3 2020 2.4m, Q4 2020 2.5m, Q1 2021 2.5m +50.0k +50,000 2.0%
18 FRAZIER LIFESCIENCES ACQU CO UNIT 12/09/2025 UNIT 12/09/2025 1,501,000 $15.2m1.22% 1.22% UnchangedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 1.5m, Q1 2021 1.5m
19 ADVERUM BIOTECHNOLOGIES INC COM COM 1,437,028 $14.2m1.14% 1.14% UnchangedShares held: Q2 2020 1.4m, Q3 2020 1.4m, Q4 2020 1.4m, Q1 2021 1.4m
20 REGENXBIO INC COM RGNX RGNX 351,954 $12.0m0.96% 0.96% AddedShares held: Q2 2020 0, Q3 2020 174.2k, Q4 2020 342.0k, Q1 2021 352.0k +10.0k +10,000 2.9%
21 GRITSTONE BIO INC COM GRTS GRTS 1,030,878 $9.7m0.78% 0.78% ReducedShares held: Q2 2020 2.1m, Q3 2020 2.1m, Q4 2020 2.1m, Q1 2021 1.0m -1.0m -1,030,880 -50.0%
22 APTINYX INC COM COM 3,190,079 $9.6m0.77% 0.77% UnchangedShares held: Q2 2020 3.2m, Q3 2020 3.2m, Q4 2020 3.2m, Q1 2021 3.2m
23 ESSA PHARMA INC COM NEW EPI EPI 316,616 $9.2m0.74% 0.74% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 316.6k
24 IMMUNOVANT INC COM IMVT IMVT 508,000 $8.1m0.65% 0.65% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 508.0k
25 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 156,000 $7.9m0.63% 0.63% AddedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 153.5k, Q1 2021 156.0k +2.5k +2,500 1.6%
26 FREELINE THERAPEUTICS HLDGS SPONSORED ADS SPONSORED ADS 550,000 $6.8m0.54% 0.54% UnchangedShares held: Q2 2020 0, Q3 2020 550.0k, Q4 2020 550.0k, Q1 2021 550.0k
27 EPIZYME INC COM EPZM EPZM 739,369 $6.4m0.52% 0.52% AddedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 731.4k, Q1 2021 739.4k +7.9k +7,933 1.1%
28 AVADEL PHARMACEUTICALS PLC SPONSORED ADR SPONSORED ADR 578,104 $5.2m0.42% 0.42% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 578.1k
29 BELLUS HEALTH INC NEW COM NEW BLU BLU 1,296,743 $4.9m0.40% 0.40% UnchangedShares held: Q2 2020 0, Q3 2020 1.3m, Q4 2020 1.3m, Q1 2021 1.3m
30 ALLENA PHARMACEUTICALS COM ALNA ALNA 3,330,373 $4.6m0.37% 0.37% UnchangedShares held: Q2 2020 3.3m, Q3 2020 3.3m, Q4 2020 3.3m, Q1 2021 3.3m
31 SIERRA ONCOLOGY INC COM NEW COM NEW 202,803 $3.5m0.28% 0.28% UnchangedShares held: Q2 2020 202.8k, Q3 2020 202.8k, Q4 2020 202.8k, Q1 2021 202.8k
32 CARDIFF ONCOLOGY INC COM CRDF CRDF 293,500 $2.7m0.22% 0.22% ReducedShares held: Q2 2020 0, Q3 2020 260.0k, Q4 2020 568.5k, Q1 2021 293.5k -275.0k -275,000 -48.4%
33 ITERUM THERAPEUTICS PLC SHS ITRMF ITRMF 1,538,316 $2.2m0.17% 0.17% UnchangedShares held: Q2 2020 1.5m, Q3 2020 1.5m, Q4 2020 1.5m, Q1 2021 1.5m
34 GALERA THERAPEUTICS INC COM COM 241,000 $2.1m0.17% 0.17% UnchangedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 241.0k, Q1 2021 241.0k
35 NABRIVA THERAPEUTICS PLC SHS SHS 425,650 $707.0k0.06% 0.06% UnchangedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 425.6k, Q1 2021 425.6k

Sold out since Q4 2020

SecurityTickerShares held beforeValue then
COLLEGIUM PHARMACEUTICAL INC COLL COLL 943,666 $18.9m943.7k shares
ROCKET PHARMACEUTICALS INC RCKT RCKT 168,000 $9.2m168.0k shares
ARS PHARMACEUTICALS INC SPRY SPRY 35,750 $1.7m35.8k shares
MINERVA NEUROSCIENCES INC NERV NERV 61,541 $144.0k61.5k shares